Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin
Authors
Keywords
Nek2B, β-Catenin, Wnt signaling pathway, Triple-negative breast cancer, Chemotherapy resistance
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-07
DOI
10.1186/s13046-019-1231-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
- (2018) Abhishek Gangrade et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma
- (2018) Reinaldo Franqui-Machin et al. JOURNAL OF CLINICAL INVESTIGATION
- The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
- (2018) Daiana Cosmina Temian et al. Journal of Breast Cancer
- Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
- (2018) Susan E. Logue et al. Nature Communications
- Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
- (2018) Yanrong Su et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
- (2018) Iris C. Salaroglio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Classification of triple-negative breast cancers based on Immunogenomic profiling
- (2018) Yin He et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2
- (2017) Jia Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Endothelial NO Synthase-Dependent S-Nitrosylation of β-Catenin Prevents Its Association with TCF4 and Inhibits Proliferation of Endothelial Cells Stimulated by Wnt3a
- (2017) Ying Zhang et al. MOLECULAR AND CELLULAR BIOLOGY
- Ixazomib enhances parathyroid hormone–induced β-catenin/T-cell factor signaling by dissociating β-catenin from the parathyroid hormone receptor
- (2017) Yanmei Yang et al. MOLECULAR BIOLOGY OF THE CELL
- Effect of NIMA-related kinase 2B on the sensitivity of breast cancer to paclitaxel in vitro and vivo
- (2017) Yahong Wang et al. TUMOR BIOLOGY
- A C-terminally truncated form of β-catenin acts as a novel regulator of Wnt/β-catenin signaling in planarians
- (2017) Hanxia Su et al. PLoS Genetics
- A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo
- (2017) Seung Ho Shin et al. EBioMedicine
- Lin28A and androgen receptor expression in ER−/Her2+ breast cancer
- (2016) Honghong Shen et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting NEK2 as a promising therapeutic approach for cancer treatment
- (2016) Yanfen Fang et al. CELL CYCLE
- Nek2 activation of Kif24 ensures cilium disassembly during the cell cycle
- (2015) Sehyun Kim et al. Nature Communications
- Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer
- (2015) Yan-Ru Zeng et al. BMC Urology
- Nek2 and Plk4: prognostic markers, drivers of breast tumorigenesis and drug resistance
- (2014) Mihaela Marina Frontiers in Bioscience-Landmark
- Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival
- (2014) Christopher P. Neal et al. JOURNAL OF SURGICAL ONCOLOGY
- Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1
- (2014) Bertrade C. Mbom et al. MOLECULAR BIOLOGY OF THE CELL
- NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
- (2013) Wen Zhou et al. CANCER CELL
- Mitotic perturbations induced by Nek2 overexpression require interaction with TRF1 in breast cancer cells
- (2013) Jaehyung Lee et al. CELL CYCLE
- Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple-negative breast cancer cells
- (2013) JAEHYUNG LEE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy
- (2013) Abhilasha Sinha et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions
- (2012) Yu-Yu Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2
- (2009) Paolo Spallarossa et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Targeting the WNT/β-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options
- (2009) Iris Gehrke et al. EUROPEAN JOURNAL OF CANCER
- -Catenin is a Nek2 substrate involved in centrosome separation
- (2007) S. Bahmanyar et al. GENES & DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation